Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-255421
Filing Date
2022-09-30
Accepted
2022-09-30 15:42:27
Documents
62
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q d403101d10q.htm   iXBRL 10-Q 823497
2 EX-31.1 d403101dex311.htm EX-31.1 10568
3 EX-31.2 d403101dex312.htm EX-31.2 10648
4 EX-32 d403101dex32.htm EX-32 5327
  Complete submission text file 0001193125-22-255421.txt   4721288

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA neog-20220831.xsd EX-101.SCH 37737
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20220831_cal.xml EX-101.CAL 34688
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20220831_def.xml EX-101.DEF 296314
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220831_lab.xml EX-101.LAB 369409
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220831_pre.xml EX-101.PRE 332544
56 EXTRACTED XBRL INSTANCE DOCUMENT d403101d10q_htm.xml XML 567266
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 221283837
SIC: 2835 In Vitro & In Vivo Diagnostic Substances